EquityCompass Risk Manager ETF
$23.09-$0.04 (-0.17%)
EquityCompass Risk Manager ETF’s quoted price sits in the upper half of its reported 52-week range, 0.26% below the high.
CBOE · EUCG · USD
Stock price, dividends
Quote as of Jun 12, 2025, 01:41 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
Euclid Capital Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Euclid Capital Growth ETF operates as an actively managed fund, pursuing its investment objectives through a disciplined strategy. It leverages systematic trend analysis, comprehensive market insights, and robust risk management to guide its portfolio decisions. During periods of lower perceived market risk, the fund allocates its capital across various U.S. and international equity sectors, investment styles, and asset classes. Conversely, when market conditions signal a higher-risk environment, it shifts its holdings into fixed income securities, cash, or cash equivalents to reduce equity exposure. It's important to note that this fund is non-diversified.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 05:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$23.09-$0.04 (-0.17%)
EquityCompass Risk Manager ETF’s quoted price sits in the upper half of its reported 52-week range, 0.26% below the high.
$25.63+$0.09 (+0.33%)
Morgan Creek-Exos Active SPAC Arbitrage ETF’s quoted price sits in the upper half of its reported 52-week range, 1.93% below the high.
$28.27-$0.15 (-0.53%)
Innovator IBD ETF Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 5.04% below the high.
$29.87-$0.02 (-0.07%)
Defiance Nasdaq Junior Biotechnology ETF’s quoted price sits in the lower half of its reported 52-week range, 27.94% below the high.
$41.93+$0.06 (+0.13%)
ProShares Managed Futures Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$51.75-$1.79 (-3.34%)
ETRACS Alerian Midstream Energy High Dividend Index ETN’s quoted price sits in the upper half of its reported 52-week range, 5.91% below the high.
$41.37+$0.04 (+0.11%)
Invesco Dynamic Retail ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$76.61$0.00 (0.0%)
ETRACS Alerian Midstream Energy Total Return Index ETN’s quoted price sits in the upper half of its reported 52-week range, 7.9% below the high.